Source: International Congress 2014 – Markers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. C. Tertemiz, A. Ozgen Alpaydin, S. Salman, A. H. Cimrin (Izmir, Turkey). Can red blood cell morphology be an indicator for COPD exacerbations?. Eur Respir J 2014; 44: Suppl. 58, 573

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Role of activated complement in COPD exacerbation recovery Source: International Congress 2014 – Comorbidities Year: 2014 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Mukoregulatory drugs in treating COPD Source: International Congress 2014 – Predictors Year: 2014 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 COPD: Influence of patients’ nutritive status on the exacerbations rate Source: International Congress 2016 – COPD diagnosis and management Year: 2016 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Importance of the initial behaviour of patients in avoiding late recovery from COPD exacerbations Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Inter-relationship of different types of respiratory symptoms in COPD Source: International Congress 2014 – Comorbidities Year: 2014